Medtronic Plc [MDT] stock prices are up 0.90% to $92.33 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MDT shares have lost -0.86% over the last week, with a monthly amount glided 1.24%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on March 04, 2025, when Citigroup upgraded its rating to a Buy and also boosted its price target to $107 from $92. Previously, RBC Capital Mkts upgraded its rating to Outperform on October 10, 2024, and elevated its price target to $105. On August 21, 2024, Oppenheimer reiterated its Perform rating and revised its price target to $94 on the stock. UBS upgraded its rating to a Neutral and increased its price target to $90 on August 15, 2024. Stifel downgraded its rating to a Hold and reduced its price target to $85 on August 14, 2024. Goldman started tracking with a Sell rating for this stock on May 30, 2024, and assigned it a price target of $83. In a note dated July 19, 2023, Robert W. Baird initiated an Neutral rating and provided a target price of $90 on this stock.
The stock price of Medtronic Plc [MDT] has been fluctuating between $75.96 and $96.25 over the past year. Currently, Wall Street analysts expect the stock to reach $98 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $92.33 at the most recent close of the market. An investor can expect a potential return of 6.14% based on the average MDT price forecast.
Analyzing the MDT fundamentals
The Medtronic Plc [NYSE:MDT] reported sales of 33.20B for trailing twelve months, representing a surge of 2.51%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.09 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 91.68 points at the first support level, and at 91.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 92.86, and for the 2nd resistance point, it is at 93.39.
Ratios To Look Out For
It’s worth pointing out that Medtronic Plc [NYSE:MDT]’s Current Ratio is 1.90. Also, the Quick Ratio is 1.43, while the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 3.57, the price to book ratio is 2.40 and price to earnings (TTM) ratio is 28.06.
Transactions by insiders
Recent insider trading involved Wall Brett A., EVP & Pres Neuroscience, that happened on Jan 24 ’25 when 12437.0 shares were sold. Officer, Wall Brett A. completed a deal on Jan 24 ’25 to buy 12437.0 shares. Meanwhile, EVP & Pres Neuroscience Wall Brett A. sold 9850.0 shares on Jan 08 ’25.
